Vaxart, Inc. (VXRT)
0.61
-0.02
(-3.13%)
USD |
OTCM |
Apr 02, 16:00
Vaxart Market Cap : 142.31M for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Inovio Pharmaceuticals, Inc. | 50.48M |
| Nuwellis, Inc. | 7.372M |
| Capricor Therapeutics, Inc. | 1.968B |
| Allogene Therapeutics, Inc. | 585.68M |
| Silvergate Capital Corp. | 297.96M |
Market Cap Related Metrics
| PE Ratio | 9.965 |
| PS Ratio | 0.5764 |
| Price to Book Value | 1.621 |
| Price to Free Cash Flow | 18.07 |
| Price | 0.61 |
| Earnings Yield | 10.04% |
| Operating PE Ratio | 7.566 |
| Normalized PE Ratio | 9.965 |